Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
종목 코드 RGC
회사Regencell Bioscience Holdings Ltd
CEO
웹사이트https://www.regencellbioscience.com/
자주 묻는 질문
Regencell Bioscience Holdings Ltd(RGC)의 현재 가격은 얼마인가요?
Regencell Bioscience Holdings Ltd(RGC)의 현재 주가는 45.790입니다.
Regencell Bioscience Holdings Ltd의 종목 기호(Symbol)는 무엇인가요?